We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.38%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMB icon
301
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.3B
$33.5M 0.08%
374,027
+190,187
+103% +$16.8M
CDNS icon
302
Cadence Design Systems
CDNS
$76.9B
$33.5M 0.08%
107,542
-108,028
-50% -$32M
GM icon
303
General Motors
GM
$76.5B
$33.3M 0.08%
734,328
+4,299
+0.6% +$167K
ZM icon
304
Zoom
ZM
$27.8B
$33.3M 0.08%
509,221
-63,653
-11% -$4.24M
AOS icon
305
A.O. Smith
AOS
$7.8B
$33.2M 0.08%
370,751
+51,858
+16% +$4.28M
ELAN icon
306
Elanco Animal Health
ELAN
$11.6B
$33.1M 0.08%
2,035,843
+31,474
+2% +$492K
BAP icon
307
Credicorp
BAP
$29.9B
$33.1M 0.08%
195,391
-3,377
-2% -$543K
BRZE icon
308
Braze
BRZE
$2.72B
$32.9M 0.08%
741,940
+237,946
+47% +$12.8M
PH icon
309
Parker-Hannifin
PH
$120B
$32.6M 0.08%
58,650
+5,910
+11% +$3M
VCEL icon
310
Vericel Corp
VCEL
$1.96B
$32.4M 0.07%
623,350
+62,931
+11% +$2.76M
ALTR
311
DELISTED
Altair Engineering Inc
ALTR
$32.3M 0.07%
374,530
+31,979
+9% +$2.72M
RPD icon
312
Rapid7
RPD
$862M
$32M 0.07%
653,352
+143,948
+28% +$7.9M
MYRG icon
313
MYR Group
MYRG
$4.23B
$32M 0.07%
181,022
+11,703
+7% +$1.8M
CART icon
314
Maplebear
CART
$11.3B
$32M 0.07%
857,825
+393,470
+85% +$11.5M
EME icon
315
Emcor
EME
$34.4B
$31.8M 0.07%
90,847
-11,709
-11% -$3.14M
XENE icon
316
Xenon Pharmaceuticals
XENE
$5.64B
$31.6M 0.07%
734,900
+388,304
+112% +$17.9M
ZNTL icon
317
Zentalis Pharmaceuticals
ZNTL
$332M
$31.5M 0.07%
1,998,700
-161,865
-7% -$2.23M
DYN icon
318
Dyne Therapeutics
DYN
$3.46B
$31.2M 0.07%
1,100,224
+725,224
+193% +$16.4M
BIO icon
319
Bio-Rad Laboratories Class A
BIO
$9.87B
$31.2M 0.07%
90,183
+10,693
+13% +$3.52M
CBU icon
320
Community Bank
CBU
$3.29B
$31.1M 0.07%
647,742
+110,898
+21% +$5.18M
LIN icon
321
Linde
LIN
$214B
$31M 0.07%
66,744
-3,681
-5% -$1.59M
NFLX icon
322
Netflix
NFLX
$334B
$31M 0.07%
509,860
+96,610
+23% +$5.45M
ROK icon
323
Rockwell Automation
ROK
$47.6B
$30.9M 0.07%
106,135
+10,022
+10% +$2.89M
GOOG icon
324
Alphabet (Google) Class C
GOOG
$4.23T
$30.9M 0.07%
202,727
+9,835
+5% +$1.42M
PVH icon
325
PVH
PVH
$3.26B
$30.8M 0.07%
219,348
-177,901
-45% -$22.8M

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.